Physician profile
Julia G Hoffman
NPI 1477585669
$6,078.95
in general payments reported to CMS, 2019-2025
38 companies · $864 in 2025
The $864 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $80.94 · 2021: $666 · 2022: $1,690 · 2023: $1,754 · 2024: $900 · 2025: $864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,353 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,353.12 |
| Education | $164.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,052.55 | 2019-2025 | |
| Evofem Biosciences, INC. | $634.34 | 2020-2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $618.29 | 2021-2025 | |
| Astellas Pharma US INC | $413.51 | 2023-2025 | Veozah, Myrbetriq |
| Organon LLC | $315.70 | 2021-2025 | Nexplanon |
| Amgen INC. | $293.89 | 2021-2025 | Evenity, Prolia, Prolia |
| Hologic Sales and Service, LLC | $259.13 | 2020-2025 | Thinprep 2000 Processor, Aptima, Third Wave |
| Sumitomo Pharma America, INC. | $226.37 | 2023-2025 | Myfembree |
| Agile Therapeutics, INC. | $219.09 | 2021-2024 | Twirla |
| Millicent US INC | $197.51 | 2024-2025 | Femlyv, Intrarosa |
| Coopersurgical, INC. | $189.40 | 2021-2024 | Paragard T 380a, Fisherbrand Disposable Liquid Infant Heel Warmer |
| Meditrina | $168.31 | 2021-2023 | |
| Shield Therapeutics INC | $141.22 | 2023-2025 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $123.94 | 2021-2023 | |
| Sage Therapeutics, LLC | $118.50 | 2024-2025 | Zurzuvae |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $116.29 | 2021-2022 | |
| Exact Sciences Corporation | $102.08 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $85.84 | 2021-2024 | |
| Ethicon US, LLC | $82.91 | 2022-2023 | Enseal X1 |
| Avion Pharmaceuticals | $82.38 | 2022-2023 | Balcoltra |
| Exeltis, USA INC. | $79.43 | 2022-2025 | Slynd |
| Myovant Sciences INC. | $71.34 | 2022 | |
| Channel Medsystems, INC. | $62.09 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $59.36 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $51.84 | 2021 | |
| Daiichi Sankyo INC. | $37.54 | 2020-2021 | |
| Dexcom, INC. | $35.27 | 2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $35.09 | 2022 | |
| Novo Nordisk INC | $29.36 | 2020-2021 | |
| Scynexis, INC. | $27.60 | 2022 | |
| Optumhealth Care Solutions, LLC | $26.77 | 2023-2025 | Eitan Medical, Vivify Health Care Team Portal 001, Vivify Health Care Team Portal |
| Axsome Therapeutics, INC. | $24.64 | 2025 | Symbravo |
| Supernus Pharmaceuticals, INC. | $20.43 | 2025 | Qelbree |
| Minerva Surgical, INC | $16.71 | 2023 | |
| Dysis Medical, INC. | $16.49 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.47 | 2021 | |
| Monaghan Medical Corporation | $15.05 | 2023 | Aeroeclipse |
| Virtus Pharmaceuticals LLC | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.